ClinVar Miner

Submissions for variant NM_001458.5(FLNC):c.3092C>T (p.Pro1031Leu)

dbSNP: rs372467579
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000793885 SCV000933263 likely benign Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant 2024-01-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV002325504 SCV002606423 uncertain significance Cardiovascular phenotype 2023-09-13 criteria provided, single submitter clinical testing The p.P1031L variant (also known as c.3092C>T), located in coding exon 20 of the FLNC gene, results from a C to T substitution at nucleotide position 3092. The proline at codon 1031 is replaced by leucine, an amino acid with similar properties. This variant has been detected in an individual from a hypertrophic cardiomyopathy cohort, and in unaffected relatives (Gómez J et al. Circ Cardiovasc Genet, 2017 Apr;10). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.